Temple Wants US FDA To Consider Including PK/PD In Labels To Inform Dosing

 
• By Michael Cipriano
  
pills
Stakeholders discussed the best ways to improve precision dosing at an FDA public meeting.

More from R&D

More from Pink Sheet